Application 050749
- Type
- NDA
- Sponsor
- ABBVIE
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | OMNICEF | CEFDINIR | FOR SUSPENSION;ORAL | 125MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | Yes | No |
| 002 | OMNICEF | CEFDINIR | FOR SUSPENSION;ORAL | 250MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | Yes | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N050749-001 | OMNICEF | CEFDINIR | 125MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | FOR SUSPENSION / ORAL | RLD | 1997-12-04 | |
| N050749-002 | OMNICEF | CEFDINIR | 250MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | FOR SUSPENSION / ORAL | RLD | 2004-07-29 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N050749-001 | OMNICEF | 125MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | FOR SUSPENSION / ORAL | RLD | 1997-12-04 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N050749-002 | OMNICEF | 250MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | FOR SUSPENSION / ORAL | RLD | 2004-07-29 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | N050749-001 | OMNICEF | 125MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | FOR SUSPENSION / ORAL | RLD | 1997-12-04 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N050749-002 | OMNICEF | 250MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | FOR SUSPENSION / ORAL | RLD | 2004-07-29 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N050749-001 | OMNICEF | 125MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | FOR SUSPENSION / ORAL | RLD | 1997-12-04 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N050749-002 | OMNICEF | 250MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | FOR SUSPENSION / ORAL | RLD | 2004-07-29 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N050749-001 | OMNICEF | 125MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | FOR SUSPENSION / ORAL | RLD | 1997-12-04 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N050749-002 | OMNICEF | 250MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | FOR SUSPENSION / ORAL | RLD | 2004-07-29 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N050749-001 | OMNICEF | 125MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | FOR SUSPENSION / ORAL | RLD | 1997-12-04 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N050749-002 | OMNICEF | 250MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | FOR SUSPENSION / ORAL | RLD | 2004-07-29 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N050749-001 | OMNICEF | 125MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | FOR SUSPENSION / ORAL | RLD | 1997-12-04 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N050749-002 | OMNICEF | 250MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | FOR SUSPENSION / ORAL | RLD | 2004-07-29 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N050749-001 | OMNICEF | 125MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | FOR SUSPENSION / ORAL | RLD | 1997-12-04 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N050749-002 | OMNICEF | 250MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | FOR SUSPENSION / ORAL | RLD | 2004-07-29 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N050749-001 | OMNICEF | 125MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | FOR SUSPENSION / ORAL | RLD | 1997-12-04 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N050749-002 | OMNICEF | 250MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | FOR SUSPENSION / ORAL | RLD | 2004-07-29 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N050749-001 | OMNICEF | 125MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | FOR SUSPENSION / ORAL | RLD | 1997-12-04 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N050749-002 | OMNICEF | 250MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | FOR SUSPENSION / ORAL | RLD | 2004-07-29 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N050749-001 | OMNICEF | 125MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | FOR SUSPENSION / ORAL | RLD | 1997-12-04 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N050749-002 | OMNICEF | 250MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | FOR SUSPENSION / ORAL | RLD | 2004-07-29 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N050749-001 | OMNICEF | 125MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | FOR SUSPENSION / ORAL | RLD | 1997-12-04 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N050749-002 | OMNICEF | 250MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | FOR SUSPENSION / ORAL | RLD | 2004-07-29 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | N050749-001 | OMNICEF | 125MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | FOR SUSPENSION / ORAL | RLD | 1997-12-04 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | N050749-002 | OMNICEF | 250MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | FOR SUSPENSION / ORAL | RLD | 2004-07-29 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N050749-001 | OMNICEF | 125MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | FOR SUSPENSION / ORAL | RLD | 1997-12-04 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N050749-002 | OMNICEF | 250MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | FOR SUSPENSION / ORAL | RLD | 2004-07-29 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N050749-001 | OMNICEF | 125MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | FOR SUSPENSION / ORAL | RLD | 1997-12-04 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N050749-002 | OMNICEF | 250MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | FOR SUSPENSION / ORAL | RLD | 2004-07-29 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N050749-001 | OMNICEF | 125MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | FOR SUSPENSION / ORAL | RLD | 1997-12-04 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N050749-002 | OMNICEF | 250MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | FOR SUSPENSION / ORAL | RLD | 2004-07-29 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | N050749-001 | OMNICEF | 125MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | FOR SUSPENSION / ORAL | RLD | 1997-12-04 | 8072bd15b7f6… | |
| 2024-05-31 18:47 UTC | 2024-05 | N050749-002 | OMNICEF | 250MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | FOR SUSPENSION / ORAL | RLD | 2004-07-29 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N050749-001 | OMNICEF | 125MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | FOR SUSPENSION / ORAL | RLD | 1997-12-04 | 5c6f7cd8ea54… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N050749-002 | OMNICEF | 250MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | FOR SUSPENSION / ORAL | RLD | 2004-07-29 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | N050749-001 | OMNICEF | 125MG/5ML | FOR SUSPENSION / ORAL | RLD | 1997-12-04 | 5d02ea3f76ae… | |
| 2022-04-08 23:34 UTC | 2022-04 | N050749-002 | OMNICEF | 250MG/5ML | FOR SUSPENSION / ORAL | RLD | 2004-07-29 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | N050749-001 | OMNICEF | 125MG/5ML | FOR SUSPENSION / ORAL | RLD | 1997-12-04 | 4b0b4de00fa7… | |
| 2022-04-04 05:41 UTC | 2022-04 | N050749-002 | OMNICEF | 250MG/5ML | FOR SUSPENSION / ORAL | RLD | 2004-07-29 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | N050749-001 | OMNICEF | 125MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | FOR SUSPENSION / ORAL | RLD | 1997-12-04 | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | N050749-002 | OMNICEF | 250MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | FOR SUSPENSION / ORAL | RLD | 2004-07-29 | 74a2ff9319b5… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Cefdinir | CEFDINIR | BluePoint Laboratories | e342b7cf-f527-476e-8119-b1fd81c58b55 | 2023-03-29 | Warnings, Adverse reactions | CEFDINIR |
| Cefdinir | CEFDINIR | Teva Pharmaceuticals USA, Inc. | a1f49fe1-b511-4f6b-a912-8ae8662d95a5 | 2023-02-01 | Warnings, Adverse reactions | CEFDINIR |
| Cefdinir | CEFDINIR | Proficient Rx LP | be963e80-e298-49a0-a52f-3d4dcded7c8c | 2022-10-01 | Warnings, Adverse reactions | CEFDINIR |
| Cefdinir | CEFDINIR | Proficient Rx LP | 8305b5d8-53b3-475a-b263-07d5fd81392a | 2022-09-01 | Warnings, Adverse reactions | CEFDINIR |
| cefdinir | CEFDINIR | Ascend Laboratories, LLC | efb5a975-75ec-46e1-ba84-f68d0b9bf36f | 2022-06-29 | Warnings, Adverse reactions | CEFDINIR |
| Cefdinir | CEFDINIR | Proficient Rx LP | 444cd2c4-836d-40d5-a307-d719fe83e763 | 2022-05-02 | Warnings | CEFDINIR |
| Cefdinir | CEFDINIR | Proficient Rx LP | f22acd90-5dc4-406d-af78-5f9c3a674647 | 2022-03-01 | Warnings, Adverse reactions | CEFDINIR |
| Cefdinir | CEFDINIR | Sandoz Inc | 38f6adf7-e26c-4764-8ec9-360813874dd4 | 2020-02-24 | Warnings, Adverse reactions | CEFDINIR |
| Cefdinir | CEFDINIR | Proficient Rx LP | f30d01e3-0839-4928-a45a-b46c89aa454c | 2019-11-01 | Warnings, Adverse reactions | CEFDINIR |
| Cefdinir | CEFDINIR | Teva Pharmaceuticals USA, Inc. | de3441e3-7fd2-4d29-a8b7-0f9b66e35c9c | 2018-08-31 | Warnings, Adverse reactions | CEFDINIR |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Documents#
| Document | Submission type | Date |
|---|---|---|
| 8173 | SUPPL | 2015-11-20 |
| 39243 | SUPPL | 2015-11-19 |
| 18169 | SUPPL | 2009-01-02 |
| 30438 | SUPPL | 2008-12-19 |
| 30437 | SUPPL | 2007-09-25 |
| 39242 | SUPPL | 2007-09-19 |
| 8172 | SUPPL | 2007-07-05 |
| 18168 | SUPPL | 2007-06-27 |
| 22216 | ORIG | 2006-01-03 |
| 39241 | SUPPL | 2005-07-21 |
| 8171 | SUPPL | 2005-07-21 |
| 30436 | SUPPL | 2004-09-03 |
| 8170 | SUPPL | 2004-07-30 |
| 30435 | SUPPL | 1999-07-14 |
| 18167 | SUPPL | 1999-07-14 |